http://www.bgandg.com/fmi.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements, regarding: (1) the reimbursement process and likelihood of coverage for Foundation's tumor tests by Medicare; and (2) Foundation's financial guidance. As a result of these false statements, Foundation stock traded at artificially inflated prices throughout the Class Period. Once the true details were made public, the complaint alleges that investors suffered damages.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: http://www.bgandg.com/fmi, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Foundation, you have until September 26, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 470870

"/> INVESTOR ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Foundation Medicine, Inc. (FMI) & Lead Plaintiff Deadline: September 26, 2017 « MarketersMedia – Press Release Distribution Services – News Release Distribution Services
MarketersMEDIA Year End Sale is Finally Back! Get up to 70% OFF on your press releases. Hurry! Limited time only.
Click Here

INVESTOR ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Foundation Medicine, Inc. (FMI) & Lead Plaintiff Deadline: September 26, 2017

NEW YORK, NY / ACCESSWIRE / September 13, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Foundation Medicine, Inc. ("Foundation" or the "Company") (NASDAQ: FMI) and certain of its officers, on behalf of shareholders who purchased Foundation securities between February 26, 2014 and November 3, 2015, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: http://www.bgandg.com/fmi.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements, regarding: (1) the reimbursement process and likelihood of coverage for Foundation's tumor tests by Medicare; and (2) Foundation's financial guidance. As a result of these false statements, Foundation stock traded at artificially inflated prices throughout the Class Period. Once the true details were made public, the complaint alleges that investors suffered damages.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: http://www.bgandg.com/fmi, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Foundation, you have until September 26, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 470870

NEW YORK, NY / ACCESSWIRE / September 13, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Foundation Medicine, Inc. ("Foundation" or the "Company") (NASDAQ: FMI) and certain of its officers, on behalf of shareholders who purchased Foundation securities between February 26, 2014 and November 3, 2015, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: http://www.bgandg.com/fmi.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements, regarding: (1) the reimbursement process and likelihood of coverage for Foundation's tumor tests by Medicare; and (2) Foundation's financial guidance. As a result of these false statements, Foundation stock traded at artificially inflated prices throughout the Class Period. Once the true details were made public, the complaint alleges that investors suffered damages.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: http://www.bgandg.com/fmi, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Foundation, you have until September 26, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 470870

Source URL: https://marketersmedia.com/investor-alert-bronstein-gewirtz-grossman-llc-reminds-shareholders-of-class-action-against-foundation-medicine-inc-fmi-lead-plaintiff-deadline-september-26-2017-2/238939

Source: AccessWire

Release ID: 238939


Latest News